Metformin and lactic acidosis in intensive care
Part of Hormones & metabolism clinical trials.
This study looks at patients in intensive care who had lactic acidosis, to see if taking metformin before admission played a role. It may help understand how metformin affects recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were 18 or older when you were in the intensive care unit
- You were in the intensive care unit at Hautepierre Hospital in Strasbourg between 2014 and 2023
- You had lactic acidosis within the first 24 hours of being in the hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how your body uses lactate and glycerol to make new sugar. It may help us understand blood sugar control in people with and without type 2 diabetes.
This study looks at how stopping a common diabetes drug (SGLT2 inhibitor) affects the body's risk of a serious condition called ketoacidosis. It may help understand who is most at risk and how to prevent it.
This study looks at patients who are in the ICU after taking too much metformin (a diabetes drug), sometimes along with another drug called dapagliflozin (Farxiga). The goal is to understand how overdose affects the body and what signs doctors should watch for.
This Phase 2 trial tests whether metformin can improve health outcomes and survival in older adults after a serious burn. You may be considered if your burn is large enough, you’re admitted quickly, and surgery is likely.
This trial tests if metformin, a medicine commonly used for diabetes, can help improve heart function in people who have a mechanical heart pump (LVAD). You may be able to join if you are between 18 and 75, have a continuous-flow LVAD, and have a condition called insulin resistance (where your body doesn't use insulin well) but your blood sugar levels are well-controlled.
This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.